These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31206846)

  • 21. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endobronchial ultrasound fine-needle aspiration biopsy of pulmonary non-small cell carcinoma with subclassification by immunohistochemistry panel.
    Collins BT
    Cancer Cytopathol; 2013 Mar; 121(3):146-54. PubMed ID: 22927132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
    Vogt AP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
    Aikawa E; Kawahara A; Hattori S; Yamaguchi T; Abe H; Taira T; Azuma K; Kage M
    Cancer Cytopathol; 2011 Oct; 119(5):335-45. PubMed ID: 21717589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
    Kriegsmann K; Cremer M; Zgorzelski C; Harms A; Muley T; Winter H; Kazdal D; Warth A; Kriegsmann M
    Pathology; 2019 Apr; 51(3):240-245. PubMed ID: 30798982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study.
    Brunnström H; Johansson L; Jirström K; Jönsson M; Jönsson P; Planck M
    Am J Clin Pathol; 2013 Jul; 140(1):37-46. PubMed ID: 23765532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.
    Ao MH; Zhang H; Sakowski L; Sharma R; Illei PB; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2014 May; 45(5):926-34. PubMed ID: 24746197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
    Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
    Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
    Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
    Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
    J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung.
    Downey P; Cummins R; Moran M; Gulmann C
    APMIS; 2008 Jun; 116(6):526-9. PubMed ID: 18754327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
    Roberts EA; Morrison LE; Behman LJ; Draganova-Tacheva R; O'Neill R; Solomides CC
    Ann Diagn Pathol; 2020 Apr; 45():151454. PubMed ID: 31923744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of clinical characteristics and differential diagnosis of the lung biopsy specimens in 99 adenocarcinoma cases and 111 squamous cell carcinoma cases: utility of an immunohistochemical panel containing CK5/6, CK34βE12, p63, CK7 and TTF-1.
    Xu XY; Yang GY; Yang JH; Li J
    Pathol Res Pract; 2014 Oct; 210(10):680-5. PubMed ID: 25063315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined double CK5/P63 stain: useful adjunct test for diagnosing pulmonary squamous cell carcinoma.
    Fatima N; Cohen C; Lawson D; Siddiqui MT
    Diagn Cytopathol; 2012 Nov; 40(11):943-8. PubMed ID: 21472873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
    Zhang C; Schmidt LA; Hatanaka K; Thomas D; Lagstein A; Myers JL
    Am J Clin Pathol; 2014 Sep; 142(3):320-4. PubMed ID: 25125621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid multiplex immunohistochemistry using the 4-antibody cocktail YANA-4 in differentiating primary adenocarcinoma from squamous cell carcinoma of the lung.
    Yanagita E; Imagawa N; Ohbayashi C; Itoh T
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):509-13. PubMed ID: 21415705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas.
    Kargi A; Gurel D; Tuna B
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):415-20. PubMed ID: 18091384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
    Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
    J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.